Posts Tagged ‘prostate cancer awareness’

Prostate Cancer: Statistics That May Surprise You

prostate cancer factsAccording to the American Cancer Society (ACS), the cancers that most frequently affect men are prostate, colon, lung and skin cancers. The most common men’s-specific cancer in America, affecting 1 in 7 men, is prostate cancer. One new case occurs every 2.3 minutes and a man dies from prostate cancer every 18 minutes.

You probably didn’t know this shocking statistic, from the Prostate Cancer Foundation: a man is 35% more likely to be diagnosed with prostate cancer than a woman is to be diagnosed with breast cancer.

Yet, despite these realities we don’t talk as openly about this as women do about a serious health condition. There are disputes about screenings for prostate cancer specifically, but I am an advocate of screening– including not only the PSA but also the digital rectal exam. From the screenings, you and your doctor will determine if biopsies are needed to detect aggressive cancers that need immediate treatment but also pick up cancers that are “quasi cancer” and safe to watch rather than treat immediately. Over a five-to-10-year period, about a third of men whose cancers are considered low risk turn worse and require treatment. When prostate cancer is caught in the early stages, the treatment options and outcomes are significantly better.

Nearly 3 million American men are currently living with prostate cancer. Emory Healthcare is committed to providing the highest quality healthcare to its patients, with the most up-to-date treatment options available. A multidisciplinary prostate cancer team — involving urology medical oncology, radiation oncology, diagnostic imaging– at Emory Saint Joseph’s Hospital and the Winship Cancer Institute of Emory University have come together to move novel treatments for advanced prostate cancer forward.

Start today and take control of your wellness.

  • Honestly discuss prostate cancer.
  • Avoid cancer-causing activities like tobacco use and excessive drinking.
  • Be proactive. Commit yourself to regular physical activity to maintain a healthy weight.
  • Know your risks and your family history.
  • Get regular check-ups; speak with your primary care physician about whether prostate screening is appropriate for you.

Find a primary physician through our Emory Healthcare Network or call Health Connection at 404-778-7777 to learn more from a registered nurse.

Winship Cancer Institute of Emory University’s Prostate Cancer Program offers a multidisciplinary approach. Our team of experienced specialists in urology, medical oncology, radiation oncology, advanced practice nursing, and social work deliver a comprehensive and coordinated approach to treating prostate cancer.

At Emory’s Winship Cancer Institute, our specialized clinicians use the latest precision medicine treatments and procedures that improve prostate cancer care. Proton therapy, a precision radiation treatment, is now one of the many technologically advanced tools to precisely and effectively treat each individual patient’s specific cancer.

 

About Dr. Sanda

Martin G. Sanda, MD is chair of the Department of Urology at Emory University School of Medicine and Director of the Prostate Cancer Center at Emory’s Winship Cancer Institute.

As a urological surgeon specializing in cancers of the prostate and bladder, Sanda focuses on developing new surgical and non-surgical approaches to cancer care and to improving the quality of life among cancer survivors. Currently, he is spearheading studies that seek to develop urine tests for detecting prostate cancer; develop benchmarks for improving quality of life among cancer survivors; and develop innovative prostate cancer vaccines.

 

RELATED RESOURCES:
Cancer Clinical Study Leads to Video Tool for Prostate Cancer Patients
Two Patients Benefit from Two Alternative Treatment Options for Prostate Cancer
PSA Screening for Prostate Cancer – A Healthy Debate
Questions on Validity of PSA Test as Prostate Cancer Screening Tool
Prostate Cancer, To Screen or Not?
Winship Cancer Institute Website

Two Patients Benefit from Two Alternative Treatment Options for Prostate Cancer

Prostate Cancer Awareness MonthWhen Mike Melton celebrated Prostate Cancer Awareness Month in September, this time, he was a survivor.

Melton was just 51 years old when he heard the words that every man fears: “You have prostate cancer.” As he researched his options for treatment, he was unsatisfied. The most common prostate cancer treatments often were described as invasive, uncomfortable and prone to side effects. But with three children, a wife and a bustling business to run, Melton couldn’t afford to wait.

“As I was doing my research, I noticed that so many men reported having side effects that no man would want, much less someone as young as I am,” says Melton. “Then I came across laser ablation during my online research, and it sounded exactly like what I was looking for because it was less invasive and has few side effects.”

Emory radiologist Sherif Nour, MD, FRCR, is one of a few radiologists nationwide performing a new, more targeted procedure called MRI-guided focal laser ablation to treat prostate cancer. Using a multi-parametric MRI that utilizes four types of sequences to collectively identify the area of the cancerous lesion, Nour can pinpoint the precise location of the tumor to verify that the procedure should take place. Once he locates the tumor, interventional MRI technology is used to selectively target and ablate the tumor while maintaining the integrity of the rest of the prostate gland. According to Nour, when compared to breast cancer in women, this new treatment is equivalent to a “male lumpectomy.”

“The options prostate cancer patients have had in the past are to either have surgery, radiation or whole gland ablation that comes with the risk of undesirable complications or to wait under their doctor’s close observation, which causes considerable stress knowing that they may have untreated cancer,” says Nour, associate professor of radiology and Imaging Sciences at Emory University School of Medicine and director of Emory’s new Interventional MRI Program. “MRI-guided focal laser ablation offers our patients who have had a positive biopsy for prostate cancer a less invasive option with minimal recovery time and fewer side effects.”

Traditionally, patients with suspected prostate cancer often undergo a more invasive form of tumor detection and biopsy that can lead to unpleasant side effects. Patients with confirmed prostate cancer may choose a “watchful waiting” approach, which can lead to anxiety. Traditional forms of treatment, such as prostatectomy or radiation, can in some cases, lead to urinary incontinence and erectile dysfunction.
Melton, who was back on the tennis court less than a month after his procedure was the first patient to undergo MRI-guided laser ablation for prostate cancer at Emory. At his three-month check-up, he was declared cancer-free.

“It’s like having a 400-pound elephant sitting on your chest that all of the sudden gets up,” says Melton. “It’s a huge relief. “

Melton is not the only Emory patient benefiting from alternative treatment options for prostate cancer. In the video below, hear from another one of our patients how he found hope and comfort after meeting Dr. Peter Rossi, an Emory radiation oncologist at Winship Cancer Institute of Emory University and, now, also practicing at Saint Joseph’s Hospital.

The 5-year survival rate for men with prostate cancer found in its early stages is nearly 100 percent. Use this time to remind the men in your life to talk to their doctors about their risk and family history and the appropriate screenings.For more information on prostate cancer treatment options at Emory, please use the linked resources below.

Related Resources: